Skip to main navigation menu Skip to main content Skip to site footer

THE ROLE OF THE SKIN MICROBIOME IN ATOPIC DERMATITIS: NEW THERAPEUTIC PERSPECTIVES

Abstract

Background: Atopic dermatitis (AD) is a chronic inflammatory skin disease characterized by intense pruritus and eczematous lesions. Its pathogenesis is increasingly linked to a profound dysbiosis of the skin microbiome, notably the overabundance of Staphylococcus aureus. Objective: This review synthesizes the current understanding of the skin microbiome's role in AD pathogenesis and critically evaluates emerging microbiome-targeted therapeutic strategies. Main Body: The review highlights that the AD skin microenvironment is characterized by a significant reduction in microbial diversity and the pathogenic dominance of S. aureus, which contributes to barrier dysfunction and inflammation. Consequently, therapeutic strategies aimed at restoring eubiosis—including the use of probiotics, prebiotics, and skin microbiota transplantation—are emerging as promising approaches to disease management. Conclusion: Targeting the skin microbiome represents a paradigm shift in dermatology, offering a novel and promising frontier for developing more effective, personalized, and long-lasting treatments for atopic dermatitis.

Keywords

atopic dermatitis, skin microbiome, Staphylococcus aureus, dysbiosis, therapeutic strategies, probiotics.

DOWNLOAD PDF

References

  1. Nutten S. Atopic Dermatitis: Global Epidemiology and Risk Factors. Ann Nutr Metab. 2015;66(suppl 1):8-16.
  2. Kong HH, Oh J, Deming C, Conlan S, Grice EA, Beatson MA, et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res. 2012 May;22(5):850-9.
  3. Nakatsuji T, Chen TH, Narala S, Chun KA, Two AM, Yun T, et al. Antimicrobials from human skin commensal bacteria protect against Staphylococcus aureus and are deficient in atopic dermatitis. Sci Transl Med. 2017 Feb 22;9(378):eaah4680.
  4. Myles IA, Earland K, Anderson ED, Moore IN, Kieh MD, Williams KW, et al. First-in-human topical microbiome transplantation with Roseomonas mucosa for atopic dermatitis. JCI Insight. 2018 May 3;3(9):e120608.
  5. Begishevich, Pakirdinov Adaham, and Fozilov Feruzjon Abdumuminovich. "NEUROLOGICAL COMPLICATIONS OF HERPES ZOSTER AND THEIR MANAGEMENT." Ethiopian International Journal of Multidisciplinary Research 12, no. 03 (2025): 77-81.
  6. Paetzold B, Willis JR, Pereira de Lima J, Knödlseder N, Brüggemann H, Quist SR, et al. Skin microbiome modulation by autologous fecal microbiota transplantation in patients with atopic dermatitis. Nat Med. 2021 Apr;27(4):644-650.

Downloads

Download data is not yet available.